Literature DB >> 15104178

Activation, subunit composition and physiological relevance of DAG-sensitive TRPC proteins.

Thomas Gudermann1, Thomas Hofmann, Michael Mederos y Schnitzler, Alexander Dietrich.   

Abstract

The classical transient receptor potential (TRP) protein family consists of seven members which share a common gating mechanism contingent on phospholipase C activation. While some family members are thought to be activated subsequent to emptying of intracellular calcium stores, others appear to be gated by as yet undefined lipid messengers. TRPC 3, 6 and 7 form a structural and functional TRPC subfamily characterized by their sensitivity towards diacylglycerols (DAGs). TRPC6 is a non-selective cation channel that is activated by DAG in a membrane-delimited fashion, independently of protein kinase C. Depletion of internal Ca2+ stores is not required for TRPC6 activity. TRPC6 mRNA and protein are abundantly expressed in smooth muscle cells and DAG-evoked Ca2+ transients can be observed in primary myocytes derived from lung and blood vessels. Thus, TRPC6 is a promising candidate for as yet unidentified non-selective cationic channels in smooth muscle cells potentially involved in vasoconstrictor-activated cation influx and myogenic tone of resistance arteries. Recent systematic studies revealed that TRPC proteins assemble into heteromultimers predominantly within the confines of distinct TRPC subfamilies. The known principles of channel complex formation will be instrumental in assessing the physiological role of distinct TRPC proteins in living cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104178

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  19 in total

Review 1.  Heteromerization of TRP channel subunits: extending functional diversity.

Authors:  Wei Cheng; Changsen Sun; Jie Zheng
Journal:  Protein Cell       Date:  2010-10-07       Impact factor: 14.870

Review 2.  Emerging roles of TRPM6/TRPM7 channel kinase signal transduction complexes.

Authors:  V Chubanov; M Mederos y Schnitzler; J Wäring; A Plank; T Gudermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 3.  Protein-protein interaction and functionTRPC channels.

Authors:  Kirill Kiselyov; Joo Young Kim; Weizhong Zeng; Shmuel Muallem
Journal:  Pflugers Arch       Date:  2005-07-26       Impact factor: 3.657

Review 4.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

5.  Transient Receptor Potential Cation Channels and Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia.

Authors:  Jose Rafael Lopez; Vikas Kaura; Phillip Hopkins; Xiaochen Liu; Arkady Uryach; Jose Adams; Paul D Allen
Journal:  Anesthesiology       Date:  2020-08       Impact factor: 7.892

Review 6.  TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.

Authors:  Stuart E Dryer; Jochen Reiser
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-04

Review 7.  Heterotrimeric G proteins, focal adhesion kinase, and endothelial barrier function.

Authors:  Tracy Thennes; Dolly Mehta
Journal:  Microvasc Res       Date:  2011-05-20       Impact factor: 3.514

Review 8.  On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease.

Authors:  K Smedlund; M Bah; G Vazquez
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2012-09

Review 9.  Stim, ORAI and TRPC channels in the control of calcium entry signals in smooth muscle.

Authors:  Youjun Wang; Xiaoxiang Deng; Thamara Hewavitharana; Jonathan Soboloff; Donald L Gill
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-09       Impact factor: 2.557

10.  TRPC3 is the erythropoietin-regulated calcium channel in human erythroid cells.

Authors:  Qin Tong; Iwona Hirschler-Laszkiewicz; Wenyi Zhang; Kathleen Conrad; David W Neagley; Dwayne L Barber; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.